Skip to content

Brain Imaging Artificial Intelligence Technology in Early Prediction of Dementia and Etiological Analysis

Brain Imaging Artificial Intelligence Technology in Early Prediction of Dementia and Etiological Analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107979
Enrollment
Unknown
Registered
2025-08-21
Start date
2025-09-09
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Interventions

Sponsors

Central Hospital of Dalian University of Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Patients with cognitive impairment or normal cognitive function screened by Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA); 3. For patients diagnosed with cognitive impairment according to the Diagnostic and Statistical Manual of mental Disorders-V (DSM-V) of the United States, trace back to the first screening of mild cognitive impairment (identified by educational based MMSE and MoCA scores). From that date, the clinical and imaging data (dynamic) of more than 3 years were retrospectively collected, and the data were complete. The control group had a dynamic medical history of more than 3 years, and the clinical and imaging dynamic data were complete; 4. Life expectancy >= 3 years; 5. Informed consent of patients or family members.

Exclusion criteria

Exclusion criteria: 1.Patients with an undetermined time of diagnosis of mild cognitive impairment; 2. Cognitive dysfunction caused by special uncontrollable factors: such as brain tumor, brain injury, surgery, acute infection, poisoning, paraneoplastic syndrome, etc; 3.Severe systemic diseases; 4. Reversible cognitive dysunction caused by metabolic diseases: such as thyroid dysfunction, vitamin B12 deficiency, alcoholism, etc.; 5. Cognitive dysfunction caused by long-term use of drugs: such as sedatives, anticholinergic drugs, antiepileptic drugs, etc.; 6. Patients participated in other interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
Cognitive function;

Secondary

MeasureTime frame
Activities of Daily Living;Anxiety and Depression;Etiological Diagnosis;

Countries

China

Contacts

Public ContactJinjie Liu

Central Hospital of Dalian University of Technology

vip2ljj@163.com+86 411 8441 2001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026